UFP TechnologiesNASDAQ: UFPT

NEWBURYPORT, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AJR Enterprises, LLC. Headquartered in St. Charles, Illinois, with additional manufacturing in the Dominican Republic, AJR Enterprises develops and manufactures single use safe patient handling systems.

GRAND RAPIDS, Mich.--(BUSINESS WIRE)--For the third consecutive year, UFP Industries was named to the FORTUNE 500 list of largest U.S. companies, landing at 493 with $7.2 bil. in revenue.

GRAND RAPIDS, Mich.--(BUSINESS WIRE)--UFP Industries (Nasdaq: UFPI) today announced that management will participate in the Stifel Cross Sector Insight Conference at the InterContinental Boston in Boston, Massachusetts, on June 4-5, 2024. To find additional information about UFP Industries, including the most recent investor presentation, please visit ufpinvestor.com. UFP Industries, Inc. UFP Industries, Inc. is a holding company whose operating subsidiaries – UFP Packaging, UFP Construction an.

NEWBURYPORT, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming CJS Securities 24th Annual “New Ideas for the New Year” Conference to be held virtually on January 10, 2024. UFP's presentation is scheduled to begin at 11:45 AM ET on Wednesday, January 10, 2024.

UFP Technologies, Inc., a niche manufacturer in the healthcare space, has seen its stock decline by 30% from its recent highs. The company has transformed itself into a more focused firm via a series of small acquisitions and one divesture. There was some heavy insider selling in the stock in May and August of this year, but last week an insider made a small purchase in the stock.

UFP Technologies, Inc. presents compelling long-term value with strong business growth and high returns on investment. The company's Q2 earnings showed positive sales trends in various markets, particularly in the medical devices segment. The company presents with a wide margin of safety based on its economic growth factors.

UFPT Technologies has caught another strong bid in FY'23. The company's MedTech business, particularly its robotic surgery sales, is driving its success, with the potential to capture market share in the future. Despite a possible short-term correction, I've revised up the long-term target for UFPT to $342/share.